Global in-Vitro Diagnostics (IVD) Market Study Report: 2014 Edition

The Report Global In-Vitro Diagnostics (IVD) Market Report: 2014 Edition provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -


Albany, NY -- (SBWIRE) -- 02/02/2015 -- An in-vitro diagnostic test is performed outside of a human body in an artificial environment (e.g. laboratory). IVD is considered as an essential part of today's healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. IVD is widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Furthermore, IVD allows earlier and more targeted treatment which in turn leads to reduced hospital stays and convalescences resulting in a healthier population and economic growth in the long run.

View Full Report

A constant growth has been observed in the global IVD industry since 2009. In IVD by technology, immunoassay and conventional chemistry strongly dominates the market. Laboratory test lead the IVD market by test location followed by self-test. Infectious disease is the largest segment covering the IVD market. On the basis of IVD products, reagent has the maximum market share.

The key factors which are anticipated to drive market growth include rising global healthcare expense, increasing global ageing population, accelerating global diabetic population apart from rising incidences of chronic and infectious diseases and increasing global gross national income. Some of the noteworthy developments of this industry include food safety testing market being taken over, development in patient monitoring and telemedicine, continued expansion of POC testing apart from mergers and acquisitions. However, the industry remains threatened by certain challenges which include lack of economies of scale and scope, increase in investment demands apart from usual regulatory, reimbursement and intellectual property issues.

Download Detail Report With Complete TOC

This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in-depth study of the IVD segments and the regional markets of Europe and China. The global IVD industry is consolidated with the top players, Abbott, Siemens, Roche and Johnson and Johnson which operate in a highly competitive environment. The above mentioned companies are being profiled along with their key financials and strategies for growth.

Explore All Latest Published Reports By Koncept Analytics

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Related Reports

China Diagnostic Reagent Industry Report, 2013-2016

View Full Report

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic reagent industry has been developing quickly, especially in vitro diagnostic reagents occupy over 90%. In 2013, Chinese in vitro diagnostics market size reached RMB22.98 billion, of which RMB16.61 billion came from in vitro diagnostic reagents.

Download Detail Report With Complete TOC

Chinese in vitro diagnostic reagent market consists of biochemical diagnostic reagents, immunodiagnostic reagents and molecular diagnostic reagents. Among them, the immune reagents and biochemical reagents account for a relatively higher combined proportion, such as around 65% in 2013.

Global Molecular Diagnostics Market Report: 2014 Edition

View Full Report

Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular, have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient samples, including blood and tissues, in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the title of 'silent champion' of the healthcare industry since this segment influences more than half of the decision-making in the overall healthcare industry.

Download Detail Report With Complete TOC

Under this umbrella, the fastest growing segment, i.e. molecular diagnostics, involves performing analysis at the molecular level, and thereby measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states of health or disease. Such diagnostic methods are capable of detecting viruses, bacteria, and parasites at a fast pace with greater sensitivity and specificity and thus, have been receiving greater inclination from physicians and affiliates.

About is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:

Contact Us:
Office: State Tower
90 Sate Street, Suite 700
Albany, NY 12207
United States
Tel: 518-618-1030
USA: Canada Toll Free: 866-997-4948